-

Gabriela Paiva1, Antônio Braga, Solange Artimos de Oliveira

  • 1Department of Maternal and Child Health, Postgraduate Program in Medical Sciences, School of Medicine, Fluminense Federal University, Niterói, the Department of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, the Postgraduate Program in Applied Health Sciences, University of Vassouras, Vassouras, the Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, the Botucatu Trophoblastic Disease Center, Botucatu Medical School Hospital, the Department of Gynecology and Obstetrics, Postgraduation Program in Tocogynecology UNESP-São Paulo State University, Botucatu, and the Hospital Moinhos de Vento, Porto Alegre, Brazil; the Section of Gynecologic Oncology, Obstetrics and Gynecology Institute, Taussig Cancer Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio; and the New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Obstetrics and gynecology
|February 19, 2026
PubMed
概括

剖腹产史增加了45%的 postmolar 妊娠 trofhoblastic 瘤的风险. 这一发现支持目前的管理,但建议增加对先前剖腹产患者的警.